Skip to content
Search

Latest Stories

FP34C submission deadline extended to May 6

Pharmaceutical Services Negotiating Committee (PSNC) notifies pharmacy contractors that the FP34C submission deadline has been extended to end of May 6.

This month the contractors get an extra day, because of a bank holiday on May 2, to submit their FP34C declaration through Manage Your Service (MYS) Portal for NHS pharmaceutical services delivered in April 2022.


PSNC added: “Contractors must also dispatch their prescription bundle to the relevant pricing division at the NHSBSA by May 6. This extended submission deadline applies to any month where one or more bank holiday occurs during the first five days of the month.”

“Please note the requirement to submit electronic Claim Notification (CN) messages or Electronic Reimbursement Endorsement Messages (EREMs) within the first five days remains unchanged. CN messages and EREMs for prescriptions dispensed in April 2022 must continue to be submitted by May 5, 2022.”

The earlier advance payment date will remain as four working days from the extended submission deadline of the sixth day of the month. Therefore, to secure access to earlier advance payments on May 12, 2022, contractors must submit their April 2022 FP34Cs through the MYS no later than May 6, 2022.

Contractors who submit their April FP34C figures late through MYS (after 6 May) will NOT receive any earlier advance payments and instead, receive their advance payments in accordance with the normal payment timetable i.e. on June 1, 2022.

Last month, over 10,700 pharmacy contractors who declared their March 2022 FP34C submission figures through the MYS by April 5 2022 received their earlier advance payments on Monday April 11 2022 (circa 20 days earlier than the normal advance payment timetable).

However, around 350 contractors submitted their FP34C figures late (after April 5). These contractors will receive their advance payments in accordance with the normal payment timetable i.e. on May 1 2022.

More For You

First daily pill for endometriosis to be available on NHS

Instead of travelling to clinics for injections, endometriosis patients can take a daily tablet at home

Getty Images

New endometriosis pill approved for NHS use, but only few patients will benefit

The National Institute for Health and Care Excellence (NICE) has approved a new pill for the treatment of endometriosis, providing hope for thousands of women affected by the debilitating condition.

The pill, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), is the first long-term daily pill approved for use in the UK to treat endometriosis, and it is expected to help about 1,000 patients every year.

Keep ReadingShow less
​RPS urges its members and fellows to vote in favour of Royal College for “a stronger, louder voice”

The Special Resolution Vote will remain open until 5 p.m. on Thursday, 24 March 2025.

Getty Images

Royal College voting begins: A historic moment in the profession’s evolution

Becoming a royal college will ensure pharmacy profession gains the recognition and authority it deserves, says RPS president Professor Claire Anderson.

Starting today (13), members and fellows of the Royal Pharmaceutical Society (RPS) will begin voting on the proposed changes to its Royal Charter, marking the beginning of a historic shift toward becoming the Royal College of Pharmacy.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less
NPA and IPA urge NHS England to release pharmacy economic analysis immediately

Pharmacy bodies call for transparency on the funding gap amid ongoing contract negotiations.

Getty Images

Pharmacy bodies demand immediate release of economic analysis

The National Pharmacy Association (NPA) and the Independent Pharmacies Association (IPA) have jointly written to NHS England, demanding the immediate release of the independent economic analysis of pharmacy finances commissioned last autumn.

An open letter, signed by the owners of 3,034 pharmacies in England, calls for transparency on the funding gap amid ongoing contract negotiations.

Keep ReadingShow less